Rocket One (RKTO) Common Equity (2017 - 2026)
Rocket One's (RKTO) quarterly Common Equity came in at $8.2 million in Q2 2026, down 15.83% year-over-year from $9.7 million in Q2 2025, and up 97.08% quarter-over-quarter from $4.2 million in Q1 2026.
Analysis
Rocket One (RKTO) Common Equity (2017 - 2026) Analysis & Trends
Rocket One has disclosed Common Equity across 10 years of filings, most recently posting $8.2 million for Q2 2026.
- In Q2 2026, Common Equity fell 15.83% year-over-year to $8.2 million; the TTM figure through Jun 2026 stood at $8.2 million (down 15.83% YoY), while the FY2025 annual figure was $6.2 million, down 10.58% from the prior year.
- Common Equity came in at $8.2 million for Q2 2026 at Rocket One, up from $4.2 million in the prior quarter.
- In the past five years, Common Equity ranged from a high of $12.8 million in Q1 2023 to a low of $4.2 million in Q1 2026.
- Average Common Equity over 5 years is $8.9 million, with a median of $8.5 million recorded in 2022.
- Year-over-year, Common Equity soared 62.31% in 2023 and tumbled 63.94% in 2026.
- Over 5 years, Common Equity stood at $6.1 million in 2022, then soared by 56.23% to $9.5 million in 2023, then declined by 27.88% to $6.9 million in 2024, then declined by 10.58% to $6.2 million in 2025, then soared by 33.34% to $8.2 million in 2026.
- Per Business Quant data, the three most recent Common Equity figures were $8.2 million in Q2 2026, $4.2 million in Q1 2026, and $6.2 million in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | 11.69 Bn |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 11.83 Bn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | 20.25 Bn |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 31.71 Bn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | 8.42 Bn |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | 6.76 Bn |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | 1.35 Bn |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | 18.85 Bn |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | 4.92 Bn |
| 10 | Rocket One | 13.86 Mn | 5.97 Mn | - | 8.20 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.20 Mn |
| Mar 31, 2026 | 4.16 Mn |
| Dec 31, 2025 | 6.15 Mn |
| Sep 30, 2025 | 8.23 Mn |
| Jun 30, 2025 | 9.74 Mn |
| Mar 31, 2025 | 11.54 Mn |
| Dec 31, 2024 | 6.88 Mn |
| Sep 30, 2024 | 7.94 Mn |
| Jun 30, 2024 | 9.88 Mn |
| Mar 31, 2024 | 8.45 Mn |
| Dec 31, 2023 | 9.54 Mn |
| Sep 30, 2023 | 11.32 Mn |
| Jun 30, 2023 | 10.86 Mn |
| Mar 31, 2023 | 12.80 Mn |
| Dec 31, 2022 | 6.11 Mn |
| Sep 30, 2022 | 8.61 Mn |
| Jun 30, 2022 | 11.22 Mn |
| Mar 31, 2022 | 7.88 Mn |
| Dec 31, 2021 | 9.88 Mn |
| Sep 30, 2021 | 13.35 Mn |